Search Results for "cinacalcet"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for cinacalcet. Results 1 to 3 of 3 total matches.
See also: Sensipar

Cinacalcet (Sensipar)

   
The Medical Letter on Drugs and Therapeutics • Sep 20, 2004  (Issue 1192)
Cinacalcet (Sensipar) ...
Cinacalcet hydrochloride (Sensipar - Amgen) has been approved by the FDA for treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on dialysis and treatment of hypercalcemia in patients with parathyroid carcinoma.
Med Lett Drugs Ther. 2004 Sep 20;46(1192):80 |  Show IntroductionHide Introduction

Extended-Release Calcifediol (Rayaldee) for Secondary Hyperparathyroidism

   
The Medical Letter on Drugs and Therapeutics • Feb 27, 2017  (Issue 1515)
. Clin J Am Soc Nephrol 2011; 6:913. 2. Cinacalcet (Sensipar). Med Lett Drugs Ther 2004; 46:80. 3. SN ...
The FDA has approved extended-release (ER) calcifediol (25-hydroxyvitamin D3; Rayaldee – Opko), a prohormone of calcitriol, the active form of vitamin D3. It is indicated for treatment of secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) who have serum total 25-hydroxyvitamin D levels <30 ng/mL.
Med Lett Drugs Ther. 2017 Feb 27;59(1515):36-7 |  Show IntroductionHide Introduction

Table: Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters (online only)

   
The Medical Letter on Drugs and Therapeutics • Feb 06, 2023  (Issue 1669)
Inhibitors Inducers 2D6 bupropion cinacalcet fluoxetine paroxetine quinidine quinine terbinafine ...
View the Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters tables
Med Lett Drugs Ther. 2023 Feb 6;65(1669):e28-30   doi:10.58347/tml.2023.1669g |  Show IntroductionHide Introduction